Title Update on the diagnosis and management of gestationaltrophoblastic disease

[1]  T. Lawrie,et al.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia. , 2016, The Cochrane database of systematic reviews.

[2]  N. Sebire,et al.  Atypical Placental Site Nodule (APSN) and Association With Malignant Gestational Trophoblastic Disease; A Clinicopathologic Study of 21 Cases , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[3]  B. Piura,et al.  Brain metastases from gestational trophoblastic neoplasia: review of pertinent literature. , 2014, European journal of gynaecological oncology.

[4]  H. Tozkır,et al.  Novel NLRP7 mutations in familial recurrent hydatidiform mole: are NLRP7 mutations a risk for recurrent reproductive wastage? , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[5]  Chien-Jui Cheng,et al.  Transformation of a post-cesarean section placental site nodule into a coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor: a case report , 2013, Diagnostic Pathology.

[6]  M. Friedlander,et al.  A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour , 2013, Case reports in obstetrics and gynecology.

[7]  Jing Zhang,et al.  Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. , 2013, The Cochrane database of systematic reviews.

[8]  N. Sebire,et al.  EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  L. Cole,et al.  Trophoblastic disease , 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[10]  W. Small,et al.  Brain metastasis in gestational trophoblastic neoplasia: an update. , 2012, The Journal of reproductive medicine.

[11]  M. Seckl,et al.  Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving? , 2012, The Journal of reproductive medicine.

[12]  J. V. van Dijck,et al.  Increase in the incidence of gestational trophoblastic disease in The Netherlands. , 2011, Gynecologic oncology.

[13]  J. Lurain.  Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. , 2011, American journal of obstetrics and gynecology.

[14]  J. Lurain.  Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. , 2010, American journal of obstetrics and gynecology.

[15]  L. Cole,et al.  Hyperglycosylated hCG, a review. , 2010, Placenta.

[16]  J. Gupta,et al.  Recurrent hydatidiform moles. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[17]  M. Seckl,et al.  The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l−1 , 2010, British Journal of Cancer.

[18]  P. Clement,et al.  Trophoblastic Lesions, Miscellaneous Primary Uterine Neoplasms, Hematopoietic Neoplasms, and Metastatic Neoplasms to the Uterus , 2008 .

[19]  N. Sebire,et al.  Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit , 2007, BJOG : an international journal of obstetrics and gynaecology.

[20]  B. Hancock,et al.  Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. , 2006, The Journal of reproductive medicine.

[21]  P. Doyle,et al.  Influence of oral contraceptives in the development of post-molar trophoblastic neoplasia--a systematic review. , 2006, Gynecologic oncology.

[22]  E. Pukkala,et al.  Epidemiology of hydatidiform mole in Finland, 1975 to 2001. , 2005, European journal of gynaecological oncology.

[23]  E. Newlands,et al.  Familial recurrent hydatidiform mole: a review. , 2004, The Journal of reproductive medicine.

[24]  H. Ngan,et al.  Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole. , 2009, Archives of pathology & laboratory medicine.

[25]  S. Steigrad.  Epidemiology of gestational trophoblastic diseases. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[26]  J. Benedet,et al.  Gestational trophoblastic neoplasia, FIGO 2000 staging and classification , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  N. Sebire,et al.  Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy , 2003, BJOG : an international journal of obstetrics and gynaecology.

[28]  N. Sebire,et al.  The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. , 2002, Human molecular genetics.

[29]  N. Sebire,et al.  Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin , 2002, The Lancet.

[30]  G. Rustin,et al.  Management of brain metastases in patients with high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[31]  G. Rustin,et al.  Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  R. Mclellan,et al.  Gestational trophoblastic disease. , 2001, Obstetrics and gynecology clinics of North America.

[33]  S. Sekiya,et al.  Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole. , 2001, Human reproduction.

[34]  Kim Jh,et al.  Changes in gestational trophoblastic tumors over four decades. A Korean experience. , 1998 .

[35]  G. Rustin,et al.  Gestational trophoblastic disease with liver metastases: the Charing Cross experience , 1997, British journal of obstetrics and gynaecology.